Use of neurofilament-light chain (NfL) in the management of patients with multiple sclerosis

June 27, 2024

Recommend to a Colleague print

 

Summarizes recent guidance on the use of NfL in clinical practice. Includes management algorithms published by Freedman et al. eBioMedicine 2024;101:104970.

8 slides

Download the slide deck

Recommend to a Colleague

Related Posts

• Fluid biomarkers in MS – the year in review
  November 25, 2024
• ECTRIMS 2024 HIGHLIGHTS – FRIDAY, SEPTEMBER 20, 2024
  September 20, 2024
• ECTRIMS 2024 slide resource
  September 18, 2024
• Utility of biomarkers in progressive MS
  August 1, 2024
• Protein biomarker panel useful for MS diagnosis, prognosis
  July 23, 2024

Go back to home page